MobbleOpen in Mobble ⇢
Health · Infectious disease · published 2026-09-01 · via World Health Organization

WHO issues emergency guidance on Ebola vaccine for Bundibugyo virus outbreak in DRC

The World Health Organization has released emergency guidance on the use of the licensed Ervebo vaccine to combat Bundibugyo virus disease outbreaks in the Democratic Republic of the Congo. The guidance, issued on August 31, 2026, comes as the current outbreak has reached approximately 6,000 cases with widespread community transmission. It outlines potential vaccination strategies to help control the spread of the disease.

Expanded Detail

EXPANDED:

The emergency guidance, dated August 31, 2026, addresses the ongoing Bundibugyo virus outbreak in the Democratic Republic of the Congo, which has reached approximately 6,000 cases with widespread community transmission. The document centers on the licensed Ervebo vaccine as a response tool.

The guidance outlines potential vaccination strategies aimed at controlling disease spread. Bundibugyo virus is one of several Ebola species, and an outbreak of this scale — roughly 6,000 cases — represents

Expanded detail and Context are AI-generated analysis; the linked article remains the authoritative source.
Read the full article at World Health Organization →
Related stories
Ebola Vaccine Doses Headed to Congo Amid Fast-Spreading Outbreak · Infectious disease
Ebola vaccine rollout begins in Democratic Republic of Congo · Infectious disease
Ongoing Ebola Outbreak in Congo Spurs Emergency Response Efforts · Infectious disease
Medical societies issue updated vaccine guidance for flu, COVID, and RSV · Public health
This summary is AI-generated and original to Mobble; the linked article is the authoritative source. Original headline: “WHO emergency guidance on the use of licensed Ebola vaccine during Bundibugyo virus disease outbreaks.” Browse more stories.